These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1588270)

  • 1. Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long-term treatment with active vitamin D (alphacalcidol).
    Lind L; Wengle B; Lithell H; Ljunghall S
    J Intern Med; 1992 Apr; 231(4):427-32. PubMed ID: 1588270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study.
    Lind L; Wengle B; Wide L; Sörensen OH; Ljunghall S
    Am J Hypertens; 1988 Oct; 1(4 Pt 1):397-402. PubMed ID: 3063290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism.
    Lind L; Wengle B; Sørensen OH; Wide L; Akerström G; Ljunghall S
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):250-6. PubMed ID: 2644746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study.
    Lind L; Wengle B; Ljunghall S
    Acta Med Scand; 1987; 222(5):423-7. PubMed ID: 3321926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study.
    Lind L; Wengle B; Wide L; Ljunghall S
    Am J Hypertens; 1989 Jan; 2(1):20-5. PubMed ID: 2643969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals.
    Lind L; Wengle B; Lithell H; Ljunghall S
    Scand J Urol Nephrol; 1991; 25(3):233-6. PubMed ID: 1947853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No major metabolic alterations accompany the hypotensive effect of active vitamin D.
    Lind L; Wengle B; Lithell H; Ljunghall S
    Ups J Med Sci; 1991; 96(3):199-204. PubMed ID: 1810079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance.
    Lind L; Lithell H; Skarfors E; Wide L; Ljunghall S
    Acta Med Scand; 1988; 223(3):211-7. PubMed ID: 3281411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure.
    Lind L; Pollare T; Hvarfner A; Lithell H; Sørensen OH; Ljunghall S
    Diabetes Res; 1989 Jul; 11(3):141-7. PubMed ID: 2697485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in primary hyperparathyroidism in relation to histopathology.
    Lind L; Hvarfner A; Palmér M; Grimelius L; Akerström G; Ljunghall S
    Eur J Surg; 1991 Aug; 157(8):457-9. PubMed ID: 1681931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study.
    Sadek T; Mazouz H; Bahloul H; Oprisiu R; El Esper N; El Esper I; Boitte F; Brazier M; Moriniere P; Fournier A
    Nephrol Dial Transplant; 2003 Mar; 18(3):582-8. PubMed ID: 12584283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis.
    Ljunghall S; Althoff P; Fellström B; Marjanovic B; Nisell J; Weiss L; Wide L
    Nephron; 1990; 55(4):380-5. PubMed ID: 2392190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements.
    Benson L; Ljunghall S; Groth T; Falk H; Hvarfner A; Rastad J; Wide L; Akerström G
    Ups J Med Sci; 1987; 92(2):147-76. PubMed ID: 2889282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases.
    Lind L; Jacobsson S; Palmér M; Lithell H; Wengle B; Ljunghall S
    J Intern Med; 1991 Jul; 230(1):29-35. PubMed ID: 2066709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of 1,25-(OH)2-vitamin D are not altered by long-term supplementation with alphacalcidol (1-OH-vitamin D3). A double-blind, placebo-controlled study.
    Lind L; Wengle B; Sörensen OH; Ljunghall S
    Exp Clin Endocrinol; 1992; 99(3):151-3. PubMed ID: 1526265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinaemia and blood pressure in a general Japanese population: the Hisayama Study.
    Ohmori S; Kiyohara Y; Kato I; Ohmura T; Iwamoto H; Nakayama K; Nomiyama K; Yoshitake T; Ueda K; Fujishima M
    J Hypertens; 1994 Oct; 12(10):1191-7. PubMed ID: 7836736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normocalcaemic, vitamin D-sufficient hyperparathyroidism - high prevalence and low morbidity in the general population: A long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden.
    Kontogeorgos G; Trimpou P; Laine CM; Oleröd G; Lindahl A; Landin-Wilhelmsen K
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):277-84. PubMed ID: 25988687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
    Fagerberg B; Berglund A; Andersson OK; Berglund G
    J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
    Malberti F; Farina M; Imbasciati E
    Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.